Statins and other drugs: Facing COVID-19 as a vascular disease
- PMID: 32562814
- PMCID: PMC7834489
- DOI: 10.1016/j.phrs.2020.105033
Statins and other drugs: Facing COVID-19 as a vascular disease
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Comment on
-
The Effects of ARBs, ACEis, and Statins on Clinical Outcomes of COVID-19 Infection Among Nursing Home Residents.J Am Med Dir Assoc. 2020 Jul;21(7):909-914.e2. doi: 10.1016/j.jamda.2020.06.018. Epub 2020 Jun 15. J Am Med Dir Assoc. 2020. PMID: 32674818 Free PMC article.
References
-
- Ackermann M., Verleden S.E., Kuehnel M., Haverich A., Welte T., Laenger F., Vanstapel A., Werlein C., Stark H., Tzankov A., Li W.W., Li V.W., Mentzer S.J., Jonigk D. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMoa2015432. - DOI - PMC - PubMed
-
- El Sabbagh A., Prasad M., Zack C.J., Widmer R.J., Karon B.S., Lerman A., Jaffe A.S. High-sensitivity troponin in patients with coronary artery endothelial dysfunction. J. Invasive Cardiol. 2018;30(11):406–410. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
